James Adams - Older Americans

Increasing patient care and access to medications as a way to tackle chronic disease is a vital consideration for the health of our senior generation. I am an Officer of an organization that advocates for an increase in care with a focus on helping people at the individual level. As Americans live longer, we believe that care should focus more on the individual receiving care and not primarily on the system to which administers it. Since patients by nature are from a wide variety of backgrounds with complex and unique health histories, the approach to care must focus on the individual. Such a focus would minimize health care costs as recipients feel more connection with their health care provider and are able to receive more personalized treatments and medicines. Ultimately, our goal should be to provide patients with more access to their doctors and enable people to deal with issues early instead of waiting for problems to worsen before addressing them. Increasing patient access to care and innovative medicines would create a dynamic shift in health care and result in a decrease of some of the most prominent chronic diseases that affect the aging population, such as diabetes, heart disease, and Alzheimer’s. According to a new study released by PhRMA this month, there are currently more than 430 innovative medicines being developed by biopharmaceutical companies to address chronic disease in older Americans. This is great news for the health of older Americans, but we need ...
Source: PHRMA - Category: Pharmaceuticals Authors: Source Type: news